Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile

Background: Acute leukemia (AL) in infants generally shows distinctive biologic features and has a poor prognosis. Aim: To study the frequency of the cytogenetic alteration of11q23 chromosome or the recombination of MLL gene in infants less than 18 months old, with acute leukemia. Patients and metho...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cabrera C,María Elena, Campbell B,Myriam, Quintana,Juan, Undurraga S,María Soledad, Ford,Anthony A, Greaves,Mel F
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2001
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000600006
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872001000600006
record_format dspace
spelling oai:scielo:S0034-988720010006000062001-09-24Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en ChileCabrera C,María ElenaCampbell B,MyriamQuintana,JuanUndurraga S,María SoledadFord,Anthony AGreaves,Mel F Genetic markers Genetic techniques Leukemia, acute lymphoblastic Background: Acute leukemia (AL) in infants generally shows distinctive biologic features and has a poor prognosis. Aim: To study the frequency of the cytogenetic alteration of11q23 chromosome or the recombination of MLL gene in infants less than 18 months old, with acute leukemia. Patients and methods: We analyzed 37 cases of AL in infants less than 18 months of age diagnosed in Chile from 1989 to 1999. The clinical features and cytogenetic/molecular defects of 11q23MLL gene rearrangement and their influence in prognosis were determined. Results: There were 18 cases of acute Lymphoblastic leukemia (ALL) characterized by female sex (67%) high presenting leukocyte count (median 99 x109/L), blast cells with a CD10 negative phenotype (50%) and 11q23/MLL rearrangement (39%). Molecular abnormalities of 11q23 were significantly associated with adverse prognosis, with an event free survival (EFS) of only 14 ± 12%. Interestingly, infants with germ line 11q23 had a very good outcome with an EFS of 73 ± 11% (p<0.025). There were 19 cases of acute myeloblastic leukemia (AML) characterized by male sex (63%) high leukocyte count (median 93 x 109/L), FAB-MS morphology (53%) and 11q23/MLL rearrangement (53%). EFS was very poor, 20 ± 9% and 33±4% for rearranged and germinal group respectively (p=NS), due to a high mortality rate during the first month of diagnosis. Conclusions: These findings demonstrate that Chilean ALL infants with 11q23 abnormalities have a very poor prognosis. However those with germinal state can enjoy a prolonged disease free survival with the current treatment protocols (Rev Méd Chile2001; 129: 634-642)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.129 n.6 20012001-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000600006es10.4067/S0034-98872001000600006
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Genetic markers
Genetic techniques
Leukemia, acute lymphoblastic
spellingShingle Genetic markers
Genetic techniques
Leukemia, acute lymphoblastic
Cabrera C,María Elena
Campbell B,Myriam
Quintana,Juan
Undurraga S,María Soledad
Ford,Anthony A
Greaves,Mel F
Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile
description Background: Acute leukemia (AL) in infants generally shows distinctive biologic features and has a poor prognosis. Aim: To study the frequency of the cytogenetic alteration of11q23 chromosome or the recombination of MLL gene in infants less than 18 months old, with acute leukemia. Patients and methods: We analyzed 37 cases of AL in infants less than 18 months of age diagnosed in Chile from 1989 to 1999. The clinical features and cytogenetic/molecular defects of 11q23MLL gene rearrangement and their influence in prognosis were determined. Results: There were 18 cases of acute Lymphoblastic leukemia (ALL) characterized by female sex (67%) high presenting leukocyte count (median 99 x109/L), blast cells with a CD10 negative phenotype (50%) and 11q23/MLL rearrangement (39%). Molecular abnormalities of 11q23 were significantly associated with adverse prognosis, with an event free survival (EFS) of only 14 ± 12%. Interestingly, infants with germ line 11q23 had a very good outcome with an EFS of 73 ± 11% (p<0.025). There were 19 cases of acute myeloblastic leukemia (AML) characterized by male sex (63%) high leukocyte count (median 93 x 109/L), FAB-MS morphology (53%) and 11q23/MLL rearrangement (53%). EFS was very poor, 20 ± 9% and 33±4% for rearranged and germinal group respectively (p=NS), due to a high mortality rate during the first month of diagnosis. Conclusions: These findings demonstrate that Chilean ALL infants with 11q23 abnormalities have a very poor prognosis. However those with germinal state can enjoy a prolonged disease free survival with the current treatment protocols (Rev Méd Chile2001; 129: 634-642)
author Cabrera C,María Elena
Campbell B,Myriam
Quintana,Juan
Undurraga S,María Soledad
Ford,Anthony A
Greaves,Mel F
author_facet Cabrera C,María Elena
Campbell B,Myriam
Quintana,Juan
Undurraga S,María Soledad
Ford,Anthony A
Greaves,Mel F
author_sort Cabrera C,María Elena
title Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile
title_short Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile
title_full Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile
title_fullStr Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile
title_full_unstemmed Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile
title_sort significado clínico y frecuencia de la alteración genético/molecular 11q23/mll en lactantes con leucemia aguda en chile
publisher Sociedad Médica de Santiago
publishDate 2001
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000600006
work_keys_str_mv AT cabreracmariaelena significadoclinicoyfrecuenciadelaalteraciongeneticomolecular11q23mllenlactantesconleucemiaagudaenchile
AT campbellbmyriam significadoclinicoyfrecuenciadelaalteraciongeneticomolecular11q23mllenlactantesconleucemiaagudaenchile
AT quintanajuan significadoclinicoyfrecuenciadelaalteraciongeneticomolecular11q23mllenlactantesconleucemiaagudaenchile
AT undurragasmariasoledad significadoclinicoyfrecuenciadelaalteraciongeneticomolecular11q23mllenlactantesconleucemiaagudaenchile
AT fordanthonya significadoclinicoyfrecuenciadelaalteraciongeneticomolecular11q23mllenlactantesconleucemiaagudaenchile
AT greavesmelf significadoclinicoyfrecuenciadelaalteraciongeneticomolecular11q23mllenlactantesconleucemiaagudaenchile
_version_ 1718435976113553408